Xiaoyun Li

机构：Fujian Medical University, Sun Yat-sen University, Renji Hospital, First Affiliated Hospital of Fujian Medical University, Sun Yat-sen University Cancer Center, Nanjing University · ORCID：0000-0001-5644-846X

发表论文 101 篇 · 总被引 11876 次 · h-index 26

代表论文

• Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trial (2023 · Nature Communications · 被引 50)
• Concurrent chemoradiotherapy followed by adjuvant cisplatin–gemcitabine versus cisplatin–fluorouracil chemotherapy for N2–3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial (2023 · The Lancet Oncology · 被引 41)
• Alpha transcranial alternating current stimulation modulates pain anticipation and perception in a context-dependent manner (2024 · Pain · 被引 13)
• Tumor-Agnostic Approvals: Insights and Practical Considerations (2023 · Clinical Cancer Research · 被引 12)
• Paclitaxel liposome, cisplatin and 5-fluorouracil-based induction chemotherapy followed by de-escalated intensity-modulated radiotherapy with concurrent cisplatin in stage IVA–IVB childhood nasopharyngeal carcinoma in endemic area: a phase II, single-arm trial (2023 · The Lancet Regional Health - Western Pacific · 被引 9)
• Statistical Considerations on the Use of RWD/RWE for Oncology Drug Approvals: Overview and Lessons Learned (2023 · Therapeutic Innovation & Regulatory Science · 被引 7)